Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2004Clinical and Vaccine ImmunologyOpen Access

Phenotypic Drug Susceptibility Assay for Influenza Virus Neuraminidase Inhibitors

View Full Paper
Ask AI
Bookmark
Share

Authors

JMJames J. McSharryLos Alamos National LaboratoryAMAnn McDonoughAlbany Medical Center HospitalBOBetty OlsonAlbany Medical Center Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

McSharry et al. (2004) studied this question.

synapsesocial.com/papers/6a8b1eefeada60f85de3b4eehttps://doi.org/10.1128/cdli.11.1.21-28.2004
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Evaluation of Neuraminidase Enzyme Assays Using Different Substrates To Measure Susceptibility of Influenza Virus Clinical Isolates to Neuraminidase Inhibitors: Report of the Neuraminidase Inhibitor Susceptibility Network2003 · 208 citations
  2. 2Plaque inhibition assay for drug susceptibility testing of influenza viruses1980 · 282 citations
  3. 3Cyclopentane Neuraminidase Inhibitors with Potent In Vitro Anti-Influenza Virus Activities2001 · 169 citations